Black Legend Capital is currently acting as a consulting advisor to a North American AI Diagnostic SaMD company. The company uses advanced, AI-powered cough analysis via a mobile app to diagnose diseases including COVID, Tuberculosis, Flu, and RSV. They’ve also developed solutions for sufferers of COPD and Asthma, and a new solution to support Olympic and professional athletes to improve their respiratory fitness. Their solutions are non-invasive, exceptionally scalable, cost efficient, and all operate with 85%+ gross margins. The company has 16 more test types on the product road map to include lung cancer, pneumonia, pertussis, and congestive heart failure. The firm has received funding and support from Microsoft, HHS’s Biomedical Advanced Research & Development Authority (BARDA), and the National Science Foundation.
